JonesTrading analyst Soumit Roy maintained a Buy rating on Aptose Biosciences (APTO - Research Report) today and set a price target of $5.00. The company's shares opened today at $0.73.Roy covers the Healthcare sector, focusing on stocks such as Mirati Therapeutics, Aeglea Biotherapeutics, and Curis. According to TipRanks, Roy has an average return of 5.8% and a 32.75% success rate on recommended stocks. The word on The Street in general, suggests a Strong Buy analyst consensus rating for Aptose Biosciences with a $7.33 average price target.See the top stocks recommended by analysts >>The company has a one-year high of $2.00 and a one-year low of $0.45.
https://www.tipranks.com/news/blurbs/jonestrading-keeps-their-buy-rating-on-aptose-biosciences-apto?utm_source=advfn.com&utm_medium=referral
Aptose Biosciences (NASDAQ:APTO)
Historical Stock Chart
From Feb 2023 to Mar 2023 Click Here for more Aptose Biosciences Charts.
Aptose Biosciences (NASDAQ:APTO)
Historical Stock Chart
From Mar 2022 to Mar 2023 Click Here for more Aptose Biosciences Charts.